| Primary |
| Schizoaffective Disorder |
21.6% |
| Schizophrenia |
19.2% |
| Depression |
11.4% |
| Bipolar Disorder |
9.6% |
| Psychotic Disorder |
9.6% |
| Anxiety |
4.2% |
| Sleep Disorder |
4.2% |
| Affective Disorder |
2.4% |
| Bipolar Ii Disorder |
1.8% |
| Delusion |
1.8% |
| Insomnia |
1.8% |
| Iron Deficiency |
1.8% |
| Major Depression |
1.8% |
| Tourette's Disorder |
1.8% |
| Aggression |
1.2% |
| Attention Deficit/hyperactivity Disorder |
1.2% |
| Bipolar I Disorder |
1.2% |
| Hypothyroidism |
1.2% |
| Overdose |
1.2% |
| Postpartum Depression |
1.2% |
|
| Weight Increased |
10.4% |
| Death |
8.3% |
| Sedation |
8.3% |
| Electrocardiogram Qt Prolonged |
6.3% |
| Aggression |
4.2% |
| Anxiety |
4.2% |
| Completed Suicide |
4.2% |
| Constipation |
4.2% |
| Diabetes Mellitus |
4.2% |
| Dyskinesia |
4.2% |
| Eye Pain |
4.2% |
| Feeling Abnormal |
4.2% |
| Heart Rate Decreased |
4.2% |
| Insomnia |
4.2% |
| Lipids Increased |
4.2% |
| Macular Degeneration |
4.2% |
| Nausea |
4.2% |
| Nephrolithiasis |
4.2% |
| No Adverse Event |
4.2% |
| Paraesthesia |
4.2% |
|
| Secondary |
| Product Used For Unknown Indication |
29.2% |
| Schizoaffective Disorder |
18.1% |
| Depression |
10.4% |
| Schizophrenia |
8.6% |
| Prophylaxis |
4.8% |
| Anxiety |
4.5% |
| Bipolar Disorder |
4.4% |
| Foetal Exposure During Pregnancy |
4.1% |
| Psychotic Disorder |
3.1% |
| Affective Disorder |
2.7% |
| Anorexia Nervosa |
1.3% |
| Sleep Disorder |
1.3% |
| Dissociative Disorder |
1.2% |
| Hyperglycaemia |
1.1% |
| Tourette's Disorder |
1.1% |
| Delusion |
0.9% |
| Mental Disorder |
0.9% |
| Hypothyroidism |
0.8% |
| Migraine With Aura |
0.8% |
| Schizoid Personality Disorder |
0.8% |
|
| Completed Suicide |
14.2% |
| Weight Increased |
9.4% |
| Sedation |
8.5% |
| Hypertension |
5.7% |
| Insomnia |
5.7% |
| Tremor |
5.7% |
| Cardiac Hypertrophy |
4.7% |
| Death |
4.7% |
| Anxiety |
3.8% |
| Dyspnoea |
3.8% |
| Eye Pain |
3.8% |
| Increased Appetite |
3.8% |
| Lactic Acidosis |
3.8% |
| Neuroleptic Malignant Syndrome |
3.8% |
| Sinus Bradycardia |
3.8% |
| Toxicity To Various Agents |
3.8% |
| Abdominal Distension |
2.8% |
| Dystonia |
2.8% |
| Hyperphagia |
2.8% |
| Hypervigilance |
2.8% |
|
| Concomitant |
| Drug Use For Unknown Indication |
37.1% |
| Product Used For Unknown Indication |
14.6% |
| Bipolar Disorder |
8.2% |
| Schizophrenia |
6.2% |
| Depression |
4.4% |
| Hiv Infection |
4.2% |
| Psychotic Disorder |
3.8% |
| Rheumatoid Arthritis |
3.5% |
| Anxiety |
2.2% |
| Insomnia |
2.2% |
| Schizophrenia, Paranoid Type |
2.0% |
| Obsessive-compulsive Disorder |
1.5% |
| Schizoaffective Disorder |
1.5% |
| Hypertension |
1.3% |
| Psoriatic Arthropathy |
1.3% |
| Tourette's Disorder |
1.3% |
| Vitamin Supplementation |
1.3% |
| Crohn's Disease |
1.1% |
| Mental Disorder |
1.1% |
| Psoriasis |
1.1% |
|
| Peripheral Vascular Disorder |
10.5% |
| Tremor |
10.5% |
| Weight Increased |
10.5% |
| Blood Creatine Phosphokinase Increased |
5.3% |
| Fatigue |
5.3% |
| Incorrect Dose Administered |
5.3% |
| Nausea |
5.3% |
| Somnolence |
5.3% |
| Anxiety |
3.5% |
| Back Pain |
3.5% |
| Constipation |
3.5% |
| Haemarthrosis |
3.5% |
| Hypertension |
3.5% |
| Injection Site Pain |
3.5% |
| Overdose |
3.5% |
| Pain |
3.5% |
| Serotonin Syndrome |
3.5% |
| Suicide Attempt |
3.5% |
| Vomiting |
3.5% |
| White Blood Cell Count Increased |
3.5% |
|
| Interacting |
| Affective Disorder |
33.3% |
| Psychotic Disorder |
23.8% |
| Schizoaffective Disorder |
23.8% |
| Dystonia |
19.0% |
|
| Salivary Hypersecretion |
33.3% |
| Tremor |
33.3% |
| Tachyphrenia |
16.7% |
| Weight Increased |
16.7% |
|
